Cart
sales@molnova.com
Fonadelpar
CAS No. 515138-06-4
Fonadelpar( NPS-005 | SJP-0035 )
Catalog No. M14788 CAS No. 515138-06-4
Fonadelpar (NPS-005,SJP-0035) is a potent, selective peroxisome proliferator activated receptor δ (PPARδ) agonist for the treatment of corneal disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1593 | In Stock |
|
| 50MG | 3222 | In Stock |
|
| 100MG | 4410 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFonadelpar
-
NoteResearch use only, not for human use.
-
Brief DescriptionFonadelpar (NPS-005,SJP-0035) is a potent, selective peroxisome proliferator activated receptor δ (PPARδ) agonist for the treatment of corneal disorders.
-
DescriptionFonadelpar (NPS-005,SJP-0035) is a potent, selective peroxisome proliferator activated receptor δ (PPARδ) agonist for the treatment of corneal disorders.Other Indication Phase 2 Clinical.
-
In VitroFonadelpar is a PPARδ agonist, used in the research of neuroparalytic keratopathy.
-
In Vivo——
-
SynonymsNPS-005 | SJP-0035
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPPAR
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number515138-06-4
-
Formula Weight504.524
-
Molecular FormulaC25H23F3N2O4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(O)COC1=C(C)C=C2C(CCC3=C(C(C)C)N=C(C4=CC=C(C(F)(F)F)C=C4)S3)=NOC2=C1
-
Chemical Name2-[[5-methyl-3-[2-[4-propan-2-yl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethyl]-1,2-benzoxazol-6-yl]oxy]acetic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Elafibranor
A nove, potent dual PPAR α/δ agonist with EC50 of 45 and 175 nM, respectively.
-
GW 6471
GW6471 is an antagonist of PPARα with IC50 of 0.24 μ M. GW6471 enhances the binding affinity of the PPAR α ligand-binding domain to the co-repressor proteins SMRT and NCoR.A specific PPARα antagonist.
-
LY518674
LY518674 decreases triglycerides and increases HDL-C and is used for the treatment of atherosclerosis.
